242
Views
1
CrossRef citations to date
0
Altmetric
Adherence and Outcomes

Adherence stages measured by patient-reported outcome instruments in adults with asthma: a scoping review

, MSc, , MD, FRCPC, FCCP, , MSc & , PhD
Pages 179-187 | Received 17 May 2018, Accepted 14 Dec 2018, Published online: 21 Jan 2019

References

  • Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2.
  • GINA. Global strategy for asthma management and prevention. 2017. Available from: http://ginasthma.org [accessed 2019 Jan 07].
  • Chastek B, Korrer S, Nagar SP, Albers F, Yancey S, Ortega H, et al. Economic burden of illness among patients with severe asthma in a managed care setting. J Manag Care Spec Pharm 2016;22:848–861. doi: 10.18553/jmcp.2016.22.7.848.
  • Papi A, Ryan D, Soriano JB, Chrystyn H, Bjermer L, Rodriguez-Roisin R, et al. Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate to severe asthma. J Allergy Clin Immunol Pract 2018;6:1989–1998.
  • Makela MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 2013;107:1481–1490.
  • Bourdin A, Halimi L, Vachier I, Paganin F, Lamouroux A, Gouitaa M, Vairon E, et al. Adherence in severe asthma. Clin Exp Allergy 2012;42:1566–1574.
  • Braido F, Baiardini I, Blasi F, Pawankar R, Canonica GW. Adherence to asthma treatments: 'We know, we intend, we advocate'. Curr Opin Allergy Clin Immunol 2015;15:49–55.
  • Barnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: Current status and future perspectives. Respir Care 2015;60:455–468. doi: 10.4187/respcare.03200.
  • D'Amato G, Vitale C, Molino A, Stanziola A, Sanduzzi A, Vatrella A, et al. Asthma-related deaths. Multidiscip Respir Med 2016;11:1–5.
  • Haynes B, Taylor DW, Sackett DL, Compliance in health care. Baltimore: The John Hopkins University Press; 1979.
  • Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 2012;73:691–705.
  • Vrijens B, Dima AL, Van Ganse E, van Boven JFM, Eakin MN, Foster JM, de Bruin M, et al. What we mean when we talk about adherence in respiratory medicine. J Allergy Clin Immunol Pract 2016;4:802–812.
  • Laforest L, Belhassen M, Devouassoux G, Didier A, Letrilliart L, Van Ganse E. Therapeutic adherence in asthma in France: a general review. Rev Mal Respir 2017;34:194–222.
  • Magnoni MS, Latorre M, Bettoncelli G, Sanchez-Herrero MG, Lopez A, Calvo E, et al. Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain. World Allergy Organ J 2017;10:13.
  • Ismaila A, Corriveau D, Vaillancourt J, Parsons D, Stanford R, Su Z, Sampalis JS, et al. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Curr Med Res Opin 2014;30:1417–1425. doi: 10.1185/03007995.2014.908827.
  • Wu AC, Butler MG, Li L, Fung V, Kharbanda EO, Larkin EK, Vollmer WM, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc 2015;12:161–166.
  • Bender BG, Hernandez Vecino RA, McGrath K, Jones S. Comparative analysis of persistence to treatment among patients with asthma or COPD receiving AirFluSal Forspiro or seretide diskus salmeterol/fluticasone propionate combination therapy. J Allergy Clin Immunol Pract 2016;4:884–889.
  • Anglada-Martinez H, Riu-Viladoms G, Martin-Conde M, Rovira-Illamola M, Sotoca-Momblona JM, Codina-Jane C. Does mHealth increase adherence to medication? Results of a systematic review. Int J Clin Pract 2015;69:9–32. doi: 10.1111/ijcp.12582.
  • Jochmann A, Artusio L, Jamalzadeh A, Nagakumar P, Delgado-Eckert E, Saglani S, et al. Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children. Eur Respir J 2017;50:1700910.
  • Lindsay JT, Heaney LG. Nonadherence in difficult asthma - facts, myths, and a time to act. Patient Prefer Adherence 2013;7:329–336.
  • Sumino K, Cabana MD. Medication adherence in asthma patients. Curr Opin Pulm Med 2013;19:49–53.
  • Boulet LP, Vervloet D, Magar Y, Foster JM. Adherence: the goal to control asthma. Clin Chest Med 2012;33:405–417.
  • Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737–745. doi: 10.1016/j.jclinepi.2010.02.006.
  • Cohen JL, Mann DM, Wisnivesky JP, Horne R, Leventhal H, Musumeci-Szabó TJ, Halm EA, et al. Assessing the validity of self-reported medication adherence among inner-city asthmatic adults: the Medication Adherence Report Scale for Asthma. Ann Allergy Asthma Immunol 2009;103:325–331. doi: 10.1016/S1081-1206(10)60532-7.
  • Mora PA, Berkowitz A, Contrada RJ, Wisnivesky J, Horne R, Leventhal H, Halm EA, et al. Factor structure and longitudinal invariance of the Medical Adherence Report Scale-Asthma. Psychol Health 2011;26:713–727. doi: 10.1080/08870446.2010.490585.
  • Unni EJ, Farris KB. Development of a new scale to measure self-reported medication nonadherence. Res Social Adm Pharm 2015;11:e133–e143.
  • Dima AL, van Ganse E, Laforest L, Texier N, de Bruin M. The Astro-Lab Group. Measuring medication adherence in asthma: Development of a novel self-report tool. Psychol Health 2017;32:1288–1307.
  • Plaza V, Fernández-Rodríguez C, Melero C, Cosío BG, Entrenas LM, de Llano LP, Gutiérrez-Pereyra F, et al. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients. J Aerosol Med Pulm Drug Deliv 2016;29:142–152.
  • Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc 2015;13:141–146. doi: 10.1097/XEB.0000000000000050.
  • Vet HCW, Eisinga A, Riphagen II, Aertgeerts B, Pewsner D, Chapter 7: Searching for Studies: The Cochrane Collaboration. Cochrane handbook for systematic reviews of diagnostic test accuracy, Version 0.4. The Cochrane Collaboration. Available from: https://methods.cochrane.org/sdt/handbook-dta-reviews [updated September 2008].
  • Gagne M, Boulet LP, Perez N, Moisan J. Patient-reported outcome instruments that evaluate adherence behaviours in adults with asthma: a systematic review of measurement properties. Br J Clin Pharmacol 2018;84:1928–1940. doi: 10.1111/bcp.13623.
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67–74.
  • Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance from self-reported versus pharmacy claims data with metered-dose inhalers. Ann Pharmacother 2001;35:997–1003.
  • Brooks CM, Richards JM, Kohler CL, Soong SJ, Martin B, Windsor RA, Bailey WC, et al. Assessing adherence to asthma medication and inhaler regimens: a psychometric analysis of adult self-report scales. Med Care 1994;32:298–307.
  • Horne R, Weinman J. Self-regulation and self-management in asthma: Exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17:17–32. doi: 10.1080/08870440290001502.
  • Horne R, Hankin M. The medication adherence report scale. Brighton, UK: University of Brighton; 2004.
  • Dima AL, Hernandez G, Cunillera O, Ferrer M, de Bruin M. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J 2015;45:994–1018. doi: 10.1183/09031936.00172114.
  • Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol 2014;77:427–445. doi: 10.1111/bcp.12194.
  • Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 2008;12:86–94.
  • De Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in medicine: A practical guide. Cambridge: Cambridge University Press; 2011.
  • Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009;62:e1–e34.
  • White E, Armstrong BK, Saracci R, The design of questionnaires: Principles of exposure measurement in epidemiology. 2nd ed. Oxford: Oxford University Press; 2008.
  • US Department of Health Human Services FDA Center for Drug Evaluation Research, US Department of Health Human Services FDA Center for Biologics Evaluation Research, US Department of Health Human Services FDA Center for Devices Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006;4:79.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.